Literature DB >> 30380176

CRTC1-MAML2 fusion in mucoepidermoid carcinoma of the breast.

Gregory R Bean1, Gregor Krings2, Christopher N Otis3, David A Solomon2, Joaquín J García4, Annemieke van Zante2, Sandra Camelo-Piragua5, Jessica van Ziffle2, Yunn-Yi Chen2.   

Abstract

AIMS: Mucoepidermoid carcinomas (MEC) are the most common malignant neoplasms of salivary glands, but are uncommon in other sites. Salivary gland MEC are most frequently associated with CRTC1-MAML2 translocations. Exceedingly rare MEC of the breast demonstrate a basal-like and often triple (oestrogen and progesterone receptor, HER2)-negative immunophenotype, with a single case previously reported to show MAML2 rearrangement, although the fusion partner was not known. Comprehensive genomic studies of breast MEC are lacking. In this study, we analysed the immunophenotype and molecular landscape of two breast MEC to elucidate the pathogenesis of these rare tumours. METHODS AND
RESULTS: Two breast MEC were subjected to capture-based next-generation DNA sequencing of 479 cancer-related genes. The presence of the CRTC1-MAML2 fusion transcript was interrogated by reverse transcriptase-polymerase chain reaction. In addition, the immunoprofiles of breast MEC were compared to salivary gland MEC. Both breast MEC harboured CRTC1-MAML2 fusions. In contrast to most triple-negative breast carcinomas of no special type, the mutational burden of MEC was very low, with one case demonstrating only an inactivating SETD2 mutation, and the other harbouring no somatic variants in genes on the panel. No copy number alterations were identified. The immunoprofiles of breast and salivary gland MEC were overlapping, but not identical.
CONCLUSIONS: The findings highlight MEC as a breast cancer subtype more closely related to its salivary gland counterpart than to basal-like/triple-negative breast cancers of no special type.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990CRTC1-MAML2zzm321990; breast cancer; cancer genetics; mucoepidermoid carcinoma; salivary gland

Mesh:

Substances:

Year:  2018        PMID: 30380176     DOI: 10.1111/his.13779

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes.

Authors:  Fresia Pareja; Arnaud Da Cruz Paula; Rodrigo Gularte-Mérida; Mahsa Vahdatinia; Anqi Li; Felipe C Geyer; Edaise M da Silva; Gouri Nanjangud; Hannah Y Wen; Zsuzsanna Varga; Edi Brogi; Emad A Rakha; Britta Weigelt; Jorge S Reis-Filho
Journal:  NPJ Breast Cancer       Date:  2020-06-05

Review 2.  Pathogenesis of Triple-Negative Breast Cancer.

Authors:  Fatemeh Derakhshan; Jorge S Reis-Filho
Journal:  Annu Rev Pathol       Date:  2022-01-24       Impact factor: 32.350

Review 3.  Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses.

Authors:  L Cima; H Kaya; C Marchiò; R Nishimura; H Y Wen; V P Fabbri; M P Foschini
Journal:  Virchows Arch       Date:  2021-08-30       Impact factor: 4.535

Review 4.  Problematic breast tumors reassessed in light of novel molecular data.

Authors:  Fresia Pareja; Britta Weigelt; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

5.  Pleomorphic adenomas and mucoepidermoid carcinomas of the breast are underpinned by fusion genes.

Authors:  Fresia Pareja; Arnaud Da Cruz Paula; Rodrigo Gularte-Mérida; Mahsa Vahdatinia; Anqi Li; Felipe C Geyer; Edaise M da Silva; Gouri Nanjangud; Hannah Y Wen; Zsuzsanna Varga; Edi Brogi; Emad A Rakha; Britta Weigelt; Jorge S Reis-Filho
Journal:  NPJ Breast Cancer       Date:  2020-06-05

6.  The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.

Authors:  Zirong Chen; Wei Ni; Jian-Liang Li; Shuibin Lin; Xin Zhou; Yuping Sun; Jennifer W Li; Marino E Leon; Maria D Hurtado; Sergei Zolotukhin; Chen Liu; Jianrong Lu; James D Griffin; Frederic J Kaye; Lizi Wu
Journal:  JCI Insight       Date:  2021-04-08

Review 7.  Molecular Pathology of Breast Tumors: Diagnostic and Actionable Genetic Alterations.

Authors:  Dara S Ross; Fresia Pareja
Journal:  Surg Pathol Clin       Date:  2021-07-08

Review 8.  Cutaneous Melanocytic Tumor with CRTC1::TRIM11 Fusion: Review of the Literature of a Potentially Novel Entity.

Authors:  Ourania Parra; Konstantinos Linos
Journal:  Biology (Basel)       Date:  2021-12-07

9.  Transcriptome Analysis Reveals MFGE8-HAPLN3 Fusion as a Novel Biomarker in Triple-Negative Breast Cancer.

Authors:  Meng-Yuan Wang; Man Huang; Chao-Yi Wang; Xiao-Ying Tang; Jian-Gen Wang; Yong-De Yang; Xin Xiong; Chao-Wei Gao
Journal:  Front Oncol       Date:  2021-06-15       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.